Legislative Assembly for the ACT: 2005 Week 12 Hansard (18 October) . . Page.. 3771..
Public Place Names Act—Public Place Names (Bruce) Determination 2005 (No 2)—Disallowable Instrument DI2005-204 (LR, 27 September 2005).
Public Sector Management Act—
Public Sector Management Amendment Standard 2005 (No 8)—Disallowable Instrument DI2005-203 (LR, 8 September 2005).
Public Sector Management Amendment Standard 2005 (No 9)—Disallowable Instrument DI2005-221 (LR, 30 September 2005).
Radiation (Council) Appointment 2005 (No 2)—Disallowable Instrument DI2005-202 (LR, 8 September 2005).
Radiation (Fees) Determination 2005 (No 2)—Disallowable Instrument DI2005-208 (LR, 26 September 2005).
Road Transport (General) Act 1999 and the Road Transport (Safety and Traffic Management) Act—Road Transport (Safety and Traffic Management) Amendment Regulation 2005 (No 2)—Subordinate Law SL2005-22 (LR, 15 September 2005).
Roads and Public Places Act—Roads and Public Places (Removable Signs) Code of Practice 2005—Disallowable Instrument DI2005-207 (LR, 26 September 2005).
Smoking (Prohibition in Enclosed Public Places) Act—Smoking (Prohibition in Enclosed Public Places) Regulation 2005, together with Regulatory Impact Statement—Subordinate Law SL2005-21 (LR, 8 September 2005).
Territory Records Act—Territory Records (Advisory Council) Appointment 2005 (No 1)—Disallowable Instrument DI2005-206 (LR, 22 September 2005).
Water and Sewerage Act—Water and Sewerage (Fees) Determination 2005 (No 2)—Disallowable Instrument DI2005-225 (without explanatory statement) (LR, 6 October 2005).
Medicinal use of cannabis
MR CORBELL (Molonglo—Minister for Health and Minister for Planning) (4.03): I seek leave of the Assembly to make a ministerial concerning the medicinal use of cannabis.
MR CORBELL: On 25 August 2004, after the defeat of the Drugs of Dependence (Cannabis for Medical Conditions) Amendment Bill proposed by Ms Kerrie Tucker MLA, I indicated to members that I would provide a detailed report to the Assembly examining the threshold issues around the provision of cannabis for medicinal use in the ACT. I am pleased today to table this report for the information of members. The report summarises the scientific evidence for and against cannabis for medicinal use, explores current legislation, regulation and policy in Australia and overseas and sets out options available in the ACT to provide cannabis for medicinal use.
The evidence for the health benefits of cannabis are mainly in the areas of control of anorexia and nausea associated with cancer therapy, relief of chronic pain and as an aid to the control of muscle spasms in neurological conditions such as multiple sclerosis.